Flavin-containing reductase: new perspective on the detoxification of nitrobenzodiazepine

Author： LinWu Shiuan-Woei   Wang Andrew H-J   Peng Fu-Chuo  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.6, Iss.8, 2010-08, pp. : 967-981

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of flavin-containing monooxgenase in drug development

By Cashman John R  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 12, 2008-12 ,pp. : 1507-1521

Informa Healthcare

Access to resources Recommend Favorite

Flavin-containing monooxygenase 3 and human disease

By Motika Meike S   Zhang Jun   Cashman John R  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 3, Iss. 6, 2007-12 ,pp. : 831-845

Informa Healthcare

Access to resources Recommend Favorite

Developmental and tissue-specific expression of human flavin-containing monooxygenases 1 and 3

By Hines Ronald N  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 2, Iss. 1, 2006-02 ,pp. : 41-49

Informa Healthcare

Access to resources Recommend Favorite

The Role of Flavin-Containing Monooxygenase (FMO) in the Metabolism of Tamoxifen and Other Tertiary Amines

By Krueger Sharon   VanDyke Jonathan   Williams David   Hines Ronald  

Drug Metabolism Reviews, Vol. 38, Iss. 1-2, 2006-05 ,pp. : 139-147

Informa Healthcare

Access to resources Recommend Favorite

Human flavin-containing monooxygenase (form 3): polymorphisms and variations in chemical metabolism

By Cashman John R  

Pharmacogenomics, Vol. 3, Iss. 3, 2002-05 ,pp. : 325-339

Future Medicine

Access to resources Recommend Favorite